Loading viewer...
investor_presentation
Format: PDF investor_presentation
Concord Biotech Limited presented financial highlights for Q2 and H1 FY24 in November 2023. The presentation outlines the company's market opportunity, business prospects, and financial performance for the first half of the fiscal year.
investor_presentation
37 Pages
Canadian Pacific Railway
Sterling Infrastructure Investor Presentation — August 2022
investor_presentationinvestor_presentation
24 Pages
Sterling Infrastructure Inc.